How Funding Slipped Away
9:25–10:00 · 35s
Jennifer recounts how market downturns, competition from insulin, and expiring patents derailed once-promising vanadium diabetes drugs.
9:25–10:00 · 35s
Jennifer recounts how market downturns, competition from insulin, and expiring patents derailed once-promising vanadium diabetes drugs.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.